Treatment of adult patients with immune thrombocytopenia after failure of first-line therapies
CADTH
Record ID 32018002264
English
Authors' objectives:
CADTH will undertake a Health Technology Assessment to review the effectiveness and cost-effectiveness of treatments for ITP in adults after failure of first-line treatments. A secondary objective will be to determine the place in therapy of splenectomy.
Details
Project Status:
Ongoing
URL for project:
https://cadth.ca/treatment-adult-patients-immune-thrombocytopenia-after-failure-first-line-therapies
URL for protocol:
https://www.cadth.ca/sites/default/files/hta-he/HT0035%20ITP%20Protocol%20Final.pdf
Anticipated Publish Date:
2022
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
Canada
MeSH Terms
- Thrombocytopenia
- Adult
- Purpura, Thrombocytopenic, Idiopathic
- Drug Therapy
- Immunoglobulins
- Immunoglobulins, Intravenous
Keywords
- Immune thrombocytopenia
- Intravenous immunoglobulins
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
<p>Canadian Agency for Drugs and Technologies in Health (CADTH)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.